Latest Asx News

Memphasys Limited is intensifying its commercial push for Felix, an innovative automated sperm separation system for IVF, backed by a landmark Middle East partnership and a fresh capital raise to scale manufacturing and sales.

AssetOwl Limited has had over $700,000 of debt forgiven by two lenders, significantly reducing its borrowings and strengthening its financial position.

Beonic Ltd has raised $4.27 million through convertible notes to fund its product development, repay upcoming debt, and advance its North African Airport Project.

MetalsTech Limited’s substantial shareholders have finalized an off-market sale of 23.6 million shares, raising over $11 million and reshaping the company’s ownership landscape.

Range International has completed the first tranche of a capital raise, securing A$1.58 million to support growth in Indonesia and the Philippines while reducing debt.

1414 Degrees has returned to trading after issuing 35.7 million shares to US investor Lind Global Fund II, with approval for an additional 14.3 million shares pending at the upcoming AGM.

Zenith Minerals has raised A$7.65 million through a strategic placement with Ida Metal Investments, strengthening its cash position to fast-track drilling at its Dulcie and Red Mountain gold projects.

Sierra Nevada Gold has successfully raised A$9.65 million through a share placement to accelerate exploration in Nevada and Saudi Arabia, while appointing former De Grey Mining chairman Simon Lill as its new Non-Executive Chairman.

Lord Resources has raised $814,000 through a strongly supported placement and is launching a $1.6 million entitlement issue to accelerate exploration at its Ilgarari Copper Project in Western Australia.

Resolution Minerals has secured US Forest Service approval to extend and expand its drilling program at the Horse Heaven project in Idaho, doubling planned holes and increasing land holdings by 600 acres.

Recce Pharmaceuticals has initiated patient dosing in its pivotal Phase 3 trial for diabetic foot infections in Indonesia, targeting a significant market with high diabetes prevalence. Interim results expected in early 2026 could accelerate regulatory approval and commercial launch.

TasFoods has agreed to sell its Pyengana Dairy business for $2 million, aiming to reduce debt and refocus on its poultry supply chain. The sale awaits shareholder approval with settlement expected by early November.